HAEM5:Myelodysplastic neoplasm with biallelic TP53 inactivation: Difference between revisions
| [checked revision] | [checked revision] |
Bailey.Glen (talk | contribs) No edit summary |
Bailey.Glen (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
==Primary Author(s)*== | ==Primary Author(s)*== | ||
Eric McGinnis, MD, Vancouver General Hospital | Eric McGinnis, MD, Vancouver General Hospital | ||
== | ==WHO Classification of Disease== | ||
= | {| class="wikitable" | ||
Myelodysplastic neoplasm with biallelic | !Structure | ||
!Disease | |||
|- | |||
|Book | |||
|Haematolymphoid Tumours (5th ed.) | |||
|- | |||
|Category | |||
|Myeloid proliferations and neoplasms | |||
|- | |||
|Family | |||
|Myelodysplastic neoplasms | |||
|- | |||
|Type | |||
|Myelodysplastic neoplasms, with defining genetic abnormalities | |||
|- | |||
|Subtype(s) | |||
|Myelodysplastic neoplasm with biallelic TP53 inactivation | |||
|} | |||
==Definition / Description of Disease== | ==Definition / Description of Disease== | ||